 Hep G2 Cells
"Hep G2 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A human liver tumor cell line used to study a variety of liver-specific metabolic functions.
| Descriptor ID |
D056945
|
| MeSH Number(s) |
A11.251.860.180.432 A11.436.348.500
|
| Concept/Terms |
Hep G2 Cells- Hep G2 Cells
- Cell, Hep G2
- Cells, Hep G2
- Hep G2 Cell
- HepG2 Cells
- Cell, HepG2
- Cells, HepG2
- HepG2 Cell
- Hep G2 Cell Line
- Hepatoblastoma G2 Cell Line
- Cell Line, Hep G2
- Cell Line, Hepatoblastoma G2
|
Below are MeSH descriptors whose meaning is more general than "Hep G2 Cells".
Below are MeSH descriptors whose meaning is more specific than "Hep G2 Cells".
This graph shows the total number of publications written about "Hep G2 Cells" by people in this website by year, and whether "Hep G2 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 | | 2011 | 0 | 3 | 3 | | 2012 | 0 | 6 | 6 | | 2013 | 0 | 8 | 8 | | 2014 | 0 | 5 | 5 | | 2015 | 0 | 4 | 4 | | 2016 | 0 | 4 | 4 | | 2017 | 0 | 1 | 1 | | 2018 | 0 | 5 | 5 | | 2019 | 0 | 4 | 4 | | 2021 | 0 | 3 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Hep G2 Cells" by people in Profiles.
-
Kakadia J, Biggar K, Jain B, Chen AW, Nygard K, Li C, Nathanielsz PW, Jansson T, Gupta MB. Mechanisms linking hypoxia to phosphorylation of insulin-like growth factor binding protein-1 in baboon fetuses with intrauterine growth restriction and in cell culture. FASEB J. 2021 09; 35(9):e21788.
-
Andres-Hernando A, Jensen TJ, Kuwabara M, Orlicky DJ, Cicerchi C, Li N, Roncal-Jimenez CA, Garcia GE, Ishimoto T, Maclean PS, Bjornstad P, Sanchez-Lozada LG, Kanbay M, Nakagawa T, Johnson RJ, Lanaspa MA. Vasopressin mediates fructose-induced metabolic syndrome by activating the V1b receptor. JCI Insight. 2021 01 11; 6(1).
-
Kolaric A, Germe T, Hrast M, Stevenson CEM, Lawson DM, Burton NP, Vörös J, Maxwell A, Minovski N, Anderluh M. Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds. Nat Commun. 2021 01 08; 12(1):150.
-
Mondal P, Sen S, Klein BJ, Tiwary N, Gadad SS, Kutateladze TG, Roy S, Das C. TCF19 Promotes Cell Proliferation through Binding to the Histone H3K4me3 Mark. Biochemistry. 2020 02 04; 59(4):389-399.
-
Platko K, Lebeau PF, Byun JH, Poon SV, Day EA, MacDonald ME, Holzapfel N, Mejia-Benitez A, Maclean KN, Krepinsky JC, Austin RC. GDF10 blocks hepatic PPAR? activation to protect against diet-induced liver injury. Mol Metab. 2019 09; 27:62-74.
-
Cui Y, Melby ES, Mensch AC, Laudadio ED, Hang MN, Dohnalkova A, Hu D, Hamers RJ, Orr G. Quantitative Mapping of Oxidative Stress Response to Lithium Cobalt Oxide Nanoparticles in Single Cells Using Multiplexed in Situ Gene Expression Analysis. . 2019 03 13; 19(3):1990-1997.
-
Sanchez-Lozada LG, Andres-Hernando A, Garcia-Arroyo FE, Cicerchi C, Li N, Kuwabara M, Roncal-Jimenez CA, Johnson RJ, Lanaspa MA. Uric acid activates aldose reductase and the polyol pathway for endogenous fructose and fat production causing development of fatty liver in rats. J Biol Chem. 2019 03 15; 294(11):4272-4281.
-
Liang H, Zhou G, Ge Y, D'Ambrosio EA, Eidem TM, Blanchard C, Shehatou C, Chatare VK, Dunman PM, Valentine AM, Voelz VA, Grimes CL, Andrade RB. Elucidating the inhibition of peptidoglycan biosynthesis in Staphylococcus aureus by albocycline, a macrolactone isolated from Streptomyces maizeus. Bioorg Med Chem. 2018 07 23; 26(12):3453-3460.
-
Chu X, Jin Q, Chen H, Wood GC, Petrick A, Strodel W, Gabrielsen J, Benotti P, Mirshahi T, Carey DJ, Still CD, DiStefano JK, Gerhard GS. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading. J Transl Med. 2018 04 24; 16(1):108.
-
Jeannot F, Taillier T, Despeyroux P, Renard S, Rey A, Mourez M, Poeverlein C, Khichane I, Perrin MA, Versluys S, Stavenger RA, Huang J, Germe T, Maxwell A, Cao S, Huseby DL, Hughes D, Bacqué E. Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones. J Med Chem. 2018 04 26; 61(8):3565-3581.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|